E.coli-derived human CD30 recombinant protein (Position: T322-K595). Human CD30 shares 60% and 57% amino acid (aa) sequences identity with mouse and rat CD30, respectively.
Alternative Names:
CD30, CD30L receptor, D1S166E, Ki 1, Ki 1 antigen, TNFRSF8
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Purity:
Immunogen affinity purified.
Form:
Liquid
Target:
Tumor necrosis factor receptor superfamily member 8
Application Dilute:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* VAT and and shipping costs not included. Errors and price changes excepted